|Tidsskrift||Journal of Human Hypertension|
|Status||Udgivet - feb. 2023|
Bibliografisk noteFunding Information:
TMB is co-chair of the Association for the Advancement of Medical Instrumentation Sphygmomanometer committee. TMB is co-chair of the American Medical Association’s Validated Device Listing Independent Review Committee. TMB has also received funding research or salary support from Resolve to Save Lives. Resolve to Save Lives is funded by Bloomberg Philanthropies, the Bill and Melinda Gates Foundation, and Gates Philanthropy. RJMs employer (University of Oxford) receives licensing and consulting fees from Omron and Sensyne for telemonitoring solutions developed from his research. NRCC reports personal fees from Resolve to Save Lives, the Pan American Health Organization, the World Bank and Switch Health Inc. outside the submitted work; and is an unpaid member of World Action on Salt, Sugar, and Health and an unpaid consultant on dietary sodium and hypertension control to numerous governmental and non-governmental organizations. RP is CEO of mmHg, provider of digital health and software services, including remote patient monitoring software. AES is on the Executive Management Board of STRIDE BP and is co-author of the World Health Organization’s technical specifications of blood pressure devices. JES is a consultant of HEARTS in the Americas, an initiative of the Pan American Health Organization. JES is principal investigator of a National Health and Medical Research Council partnership grant (S0026615) that includes a medical technology company that manufactures a central blood pressure monitor. MPS has received research support from Medtronic, Abbott, Metavention, Recor, and Boehringer Ingelheim and personal fees/travel support from Medtronic and Abbott. GSS is chairing the STRIDE BP organization for blood pressure measurement methods and devices, conducted validation studies of blood pressure monitors, and advised manufacturers on device and software development. MT has received unrestricted gift in kind from Omron for the purpose of a clinical study. None of the other authors have disclosures.